Formycon AG (XTER:FYB) reports significant biosimilar milestones and financial resilience despite a dip in revenue and ongoing legal hurdles.

While we think Terumo can deliver its top-line growth, an operating margin of 20% is unlikely. First, for the C&V division, Terumo is in the ramp-up phase for its newly launched neurovascular or ...

The publisher has been vigilantly tracking the diverse markets within Saudi Arabia Pharmaceutical Packaging Market . This report presents an extensive analysis, encompassing market size, projections, ...

How can drug delivery devices manage competing priorities - reducing overall carbon footprint without expense to patient and ...

A 32-year-old man was fined S$266,500 in September 2024 for possessing and supplying 126 types of cosmetic products which ...

The eight platforms are Amazon Singapore, Carousell, eBay Singapore, Facebook, Lazada, Qoo10, Shopee and TikTok.

According to a recent market study, the top three countries are projected to collectively account for approximately 35 to 40% ...

This acquisition includes substantially all of the existing assets and infrastructure at MedXL facilities, such as intellectual property, real estate, manufacturing equipment, and global product ...

Exenatide is a GLP-1 agonist indicated as an adjunct to diet and exercise to improve glycemic control in adults with Type 2 diabetes mellitus.

At the recent SEC meeting for analgesics and rheumatology, the expert panel reviewed the proposed Phase I study protocol of ...